0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
40 Ansichten12 Seiten
Heart is a hollow vascular organ located between the lungs in the mediastinum. Heart has 4 chambers: (2) atria and (2) ventricles separated by a interventricular septum.
Heart is a hollow vascular organ located between the lungs in the mediastinum. Heart has 4 chambers: (2) atria and (2) ventricles separated by a interventricular septum.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOCX, PDF, TXT herunterladen oder online auf Scribd lesen
Heart is a hollow vascular organ located between the lungs in the mediastinum. Heart has 4 chambers: (2) atria and (2) ventricles separated by a interventricular septum.
Copyright:
Attribution Non-Commercial (BY-NC)
Verfügbare Formate
Als DOCX, PDF, TXT herunterladen oder online auf Scribd lesen
O Delivers oxygenated blood to tissues O Removes wastes products
HEART O Hollow vascular organ O Size oI a closed Iist; located between the lungs in the mediastinum O Weighs about 250-300 gms O Leading into and out oI the heart are the great vessels: I inIerior vena cava S superior vena cava A aorta P pulmonary artery & (4) pulmonary veins O 4 chambers: (2) atria & (2) ventricles separated by a interventricular septum O 2 sets oI valves: Atrioventricular valves (tricuspid & mitral) Semilunar valves (pulmonic & aortic) O Deoxygenated venous blood returns to the right atrium through three vessels: S superior vena cava (returning blood Irom the upper body) I inIerior vena cava (returning blood Irom the lower body) C coronary sinus (returning blood Irom the heart muscle
O Contractions oI the heart occur in a rhythm
SA node
AV node
Bundle oI His RBB LBB
SA NODE O Pacemaker; initiates heartbeat O At the junction oI the vena cava and R atrium O enerates electrical impulses at 60-100 x per min O Controlled by the sympathetic and parasympathetic nervous system
AV NODE O Located in the lower aspect oI the atrial septum O Receives electrical impulses Irom the SA node
BUNDLE OF HIS (Atrioventricular bundle) O Fuses with AV node to make another pacemaker site O Branches into RBB which extends down the right side oI the interventricular septum and LBB which extends into the leIt ventricle O %erminates into purkinje Iibers O Can initiate and sustain a heart rate at 40-60 beats/min
HEART SOUNDS O S1 closure oI the AV valves O S2 closure oI the Semilunar valves O S3 ventricular gallop due to rapid Iilling oI the ventricle. Increased leIt atrial pressure (which propels the blood Iorward with increased Iorce) and noncompliance oI the leIt ventricle, i.e. CHF, valvular regurgitation; normally heard in 30 years old, young healthy athletes O S4 atrial gallop; produced as leIt atrial systole propels volume into the leIt ventricle just prior to ventricular systole; reverberation oI blood ejected Irom the leIt atrium into the leIt ventricle, i.e. CHF
HEART RATE O Normal heart rate 60-100 beats/min O Sinus tachycardia ~ 100 O Sinus bradycardia 60 O CO SV x HR O AP CO x %PR
AUTONOMIC NERVOUS SYSTEM O Sympathetic Nervous System Decrease BP detected
VASCULAR SYSTEM O Network oI arteries, arterioles, capillaries, venules and veins O Constantly Iilled with about 5 L oI blood O Arteries carry oxygenated blood away Irom the heart; tough elastic layer to propel blood to the arterial system O Capillaries exchange oI Iluids,, nutrients and metabolic wastes products; thin walled; highly permeable; connected to arteries and veins O Veins carry unoxygenated blood to the heart; thinner, more pliable that the artery wall; has valves that helps return blood against the Ilow oI gravity
COMMON DIAGNOSTIC EXAMS
CARDIAC ENZYMES 1. CK-B (creatinine kinase, myocardial muscle) O Elevation indicates myocardial damage O Elevates within 4-6 hrs O Peaks in 18-24 hrs II the attack O Remains elevated up to 72 hrs O Normal value: 12-70 U/ml () 10-55 U/ml (F)
2. LDH (lactate dehydrogenase) O Elevates w/in 24 hrs II attack O Peaks in 48-72 hrs O Normal value: 45-90 U/L
3. %roponins O Has 3 proteins: cardiac troponin, troponin I & troponin % O %roponin % may be Iound in skeletal muscle; Sn 94, Sp 60 O %roponin I cardiac speciIic; has high aIIinity Ior myocardial injury; Sn 95, Sp 90 O Elevates in 3 hrs; peaks in 14-20 hrs; lasts up to 7 days; O N value: ~0.6 ng/ml
4. OLOBIN oxygen binding protein in cardiac and skeletal muscles; not speciIic Ior myocardial injury O Elevates w/in 1 hr aIter cell death O Peaks in 4-6 hrs O Returns to normal in 24-36 hrs
Nursing Interventions: O uscle trauma caused by I injections can raise the CK levels O Handle the collection tube gently to prevent hemolysis and send immediately to the laboratory
SERUM LIPIDS O Lipid proIile measures serum cholesterol, triglycerides and lipoprotein level O Assesses the risk Ior CAD O Normal values: Serum cholesterol 200mg/dl LDL 130 mg/dl HDL 30-70 mg/dl
GRAPHIC RECORDING STUDIES 1. EC (electrocardiogram) O Non-invasive; evaluates Iunction oI the heart by recording electrical activity
2. Holter onitoring ambulatory EC; allows recording oI heart activity as the patient Iollows his normal activity O Patient wears a small tape recorder connected to bipolar electrodes placed on his chest; lasts Ior 24 hrs O Patient keeps a diary oI his activities and associated symptoms O Record intermittent arrhythmias
Nursing Interventions: O Advise not to tamper monitor or disconnect the wires/electrodes O Not allowed to shower or bath while wearing the monitor O Emphasize the need to keep track oI his activities regardless oI symptoms
3. Exercise EC/ Stress %est O Non-invasive, assess cardiovascular response to an increase workload; threadmill is most commonly used O Detects and evaluates CAD O ay be used with myocardial nuclide testing (perIusion imaging) an invasive procedure O %he procedure is stopped once the patient Ieels chest discomIort, Iatigue, exercise intolerance, dyspnea, claudication, weakness, dizziness, hypotension, pallor, disorientation or EC changes O II patient can`t tolerate exercise, the stress test can be perIormed by IV injections oI coronary vasodilator (Dypiridamole or Adenosine) to dilate coronary arteries and stimulate eIIect oI exercise
Nursing Intervention: Pre: O Obtain inIormed consent O Advise adequate rest O Advise light meal 1-2 hrs beIore the procedure O Avoid smoking, alcohol and caIIeine O Check doctor`s orders to determine which cardiac meds should be withheld or given O Advise to wear comIortable clothing and shoes Post: O onitor patient`s BP and EC Ior 10-15 minutes O NotiIy physician Ior any chest pain, SOB, dizziness or hypotension O Wait at least 2 hours beIore showering; advise to use warm water
4. Echocardiogram O Noninvasive imaging technique based on the principles oI ultrasound O Detects structural and Iunctional changes
Nursing Intervention: O Advise to lie still during the procedure O ay resume activities as ordered
RADIONUCLIDE IMAGING TESTS 1. CARDIAC CA%HE%ERIZA%OIN & CORONAR ANIORAPH O %wo common invasive tests O A catheter is threaded through an artery (LeIt sided catheterization) or vein (right sided catheterization) into the heart O Detects structure, perIormance oI the heart valves and circulatory system; measures oxygen saturation
Nursing Intervention: Pre: O Obtain inIormed consent O Assess allergy to seaIoods, iodine or radiopaque dyes O Withhold solid Ioods Ior 6-8 hrs and liquids Ior 4 hrs to prevent aspiration and vomiting O Document height, weight, vital signs and note quality and presence oI peripheral pulses O InIorm that patient may Ieel Ilattery Ieeling as the catheter is passed through the heart; a Ilushed, warm Ieeling when the dye is injected O Post: O onitor vital signs, cardiac rhythm at least every 30 mins Ior 2 hours initially O Assess Ior chest pain, or dysrhythmias O onitor peripheral pulses (color, warmth, sensation) oI extremity (notiIy iI with tingling, numbness, cool, pale, cyanosis or loss oI pulses) O Assess pressure dressing Ior any bleeding or hematoma O Keep aIIected extremity extended and immobilized Ior 4-6 hrs and keep leg straight to prevent arterial occlusion O Strict bed rest Ior 6-12 hrs; do not elevate the head oI the bed ~ 15 degrees, however patient may turn to sides O Encourage Iluid intake to promote excretion oI dye O Assess Ior hypersensitivity reaction
2. CEN%RAL VENOUS PRESSURE (CVP) O easure oI the mean pressure within the superior vena cava O Indicates pressure caused by the blood returned to the superior vena cava and right atrium or preload O Normal CVP pressure is 3-8 mmHg O onitors the volume status
easuring CVP: O Place the patient in supine position with head oI the bed elevated at 45 degrees O %he right atrium is located at the midaxillary line at the 4 th ICS. %he zero point oI the transducer need to be at the level oI the right atrium O Advise patient to relax and avoid coughing or straining
CARDIOVASCULAR DISORDERS
1. CORONARY ARTERY DISEASE O Narrowing or obstruction oI arterial lumina that interIeres with cardiac perIusion O As a result oI accumulation oI lipid containing plaque in the arteries (atherosclerosis) O Coronary artery narrowing is signiIicant iI the lumen diameter oI the leIt main artery is reduced at least 50 or iI any major branch is reduced at least 75 O ay lead to hypertension, angina, dysrhythmias, I, heart Iailure and death
Risk Factors: O Family history oI heart disease O Hypertension, D, hyperlipidemia O Obesity O Smoking O High Iat, high carbohydrate diet O Sedentary liIestyle
Pathophysiology: Deposition oI Iatty Iibrous plaques
Progressive occlusion oI coronary arteries
Decreased myocardial perIusion
Decreased oxygen supply
Ischemia
Assessment: O Normal Iindings during asymptomatic periods O Angina, is the classic symptom oI CAD O Nausea, vomiting, weakness, diaphoresis, cool extremities
Diagnostic Exams: O EC S% segment depression or % wave inversion (ischemia); S% segment elevation, Iollowed by % wave inversion (inIarction) O Cardiac catheterization most deIinite source Ior diagnosis; shows presence oI atherosclerotic plaque O Blood lipid levels may be elevated
Interventions: %he goal oI treatment is to provide relieI oI an acute attack, correct the imbalance between the myocardial oxygen supply & demand and prevent the progression oI the disease and Iurther attacks to reduce the risk oI I.
ANGINA O Chest pain resulting Irom myocardial ischemia due to inadequate blood and oxygen supply to the myocardium O Has 4 major Iorms: 1. Stable also called exertional angina; pain that`s predictable in Irequency, severity and duration; relieved with nitrates and rest 2. Unstable also called preinIarction angina; unpredictable degree oI exertion, duration and severity over time; may not be relieved with nitroglycerin 3. Prinzemetal also called variant angina; due to coronary artery spasm; may occur at rest
Assessment: O Pain develops slowly or quickly; described as substernal, crushing, squeezing pain; may radiate to shoulders, arms, jaw, neck & back; usually lasts 5 minutes but can last up to 15-20 minutes; relieved by nitroglycerin or rest O Dyspnea O Pallor & cold, clammy skin O Sweating O Palpitations, tachycardia O Dizziness, Iaintness
Diagnostic Exams: O EC S% depression or elevation and/or % wave inversion during an episode oI angina attack O Stress %est changes in EC may indicate ischemia O Cardiac enzymes normal O Cardiac catheterization provides inIormation about patency oI coronary arteries; deIinitive diagnosis
Nursing Interventions: Immediate management: O Assess pain O aintain bed rest O Administer oxygen at 3 L/min O Administer nitroglycerin as prescribed to dilate the coronary arteries, reduce oxygen requirements oI the myocardium and relieve the chest pain O Obtain 12 lead EC
Following acute episode: O Assist the client to identiIy angina- precipitating events: 4E`s ( Eating heavy meals, Exercise, Extreme temperatures & Emotions) O Instruct to stop activity and rest iI chest pain occurs and to take nitroglycerin as prescribed O Instruct to seek medical attention iI the pain persists O Assist client to identiIy risk Iactors that can be modiIied
. MYOCARDIAL INFARCTION O Occlusion oI a coronary artery that leads to oxygen deprivation, myocardial ischemia and eventually necrosis O Extent oI myocardial impairment and the patient`s prognosis depend on the size and location oI the inIarct, the condition oI the uninvolved myocardium, the potential Ior collateral circulation and the eIIectiveness oI compensatory mechanisms.
Pathophysiology: - hypercoagulability conditions - atherosclerotic plaque ruptures - thrombus Iormation at the site oI vascular injury
thrombotic occlusion oI coronary artery
myocardial ischemia
anaerobic metabolism (lactic acid Iormation, blood pH, K loss)
myocardial necrosis
deterioration oI ventricular perIormance
cardiac output & oxygen supply
activation oI the autonomic nervous system
Risk Factors: O Atherosclerosis O CAD O Hypercholesterolemia O Smoking O Hypertension, Obesity O Physical inactivity
Diagnostic Exams: O Cardiac enzymes CK-B, LDH, & troponin are elevated O EC - S% segment elevation, % wave inversion, & abnormal Q wave O CBC elevated WBC count on the 2 nd
day II I O Other exams done aIter the acute stage: O Exercise %olerance %est O %hallium scans O ultigated cardiac blood pool imaging scans O Cardiac catheterization
Assessment: O Pain (crushing sternal pain with radiation to the jaw, back and leIt arm, occur without cause, unrelieved by rest or nitrates & lasts ~ 30 mins O Cold, clammy skin O Dyspnea O Sense oI impending doom O Pallor, cyanosis O %achy or bradycardia O Hypo or hypertension
Nursing Interventions: (Acute stage) O Assess cardiovascular status and maintain cardiac monitoring O Place patient in semi-Iowler position to enhance comIort and breathing O Administer oxygen 2 4 L/min by nasal cannula as prescribed O Obtain 12 lead EC O Administer medications as prescribed: - Nitroglycerin - orphine - %hrombolytics, aspirin, anticoagulant - Beta blockers - Stool soIteners
Following acute episode: O onitor Ior complications related to I O aintain bed rest Ior the Iirst 24 36 hrs O Allow to stand or use bedside commode iI prescribed O Progress Irom dangling oI legs at the side oI the bed Ior 30 mins 3x a day to ambulation in the client`s room then in the hallway 3x a day as prescribed
3. HEART FAILURE O Inability oI the heart to maintain adequate circulation to meet the metabolic needs oI the body because oI an impaired pumping capability O Diminished cardiac output; inadequate peripheral perIusion O Congestion oI the lungs and periphery occur
ClassiIied as: O Acute or chronic O LeIt sided or right sided O Systolic or diastolic
Risk Factors: O CAD O I O Hypertension O Rheumatic heart disease O Congenital heart disease O Ischemic heart disease O Arrhythmias
Noncardiovascular causes: O Pregnancy O Increase environmental temp or humidity O Severe physical or mental states O %hyrotoxicosis O Anemia, acute blood loss O COPD
Assessment: Right sided heart Iailure: O Signs oI RHF evident in the systemic circulation O Dependent edema O Distended neck veins O Hepatojugular reIlex O Ascites O Hepatomegaly O Fatigue O Weight gain
LeIt sided heart Iailure: O S/Sx are evident in the pulmonary system O Productive cough, Irothy sputum O Dyspnea on exertion O Orthopnea, paroxysmal nocturnal dyspnea O Crackles or rales O Fatigue O Pallor, cyanosis O ConIusion and disorientation
Compensatory echanism: %he body`s response to decreased cardiac output: O ReIlex increase in sympathetic activity O Release oI rennin Irom the juxtaglomerular cells oI the kidney O Anaerobic metabolism by aIIected cells O Increase extraction oI oxygen by the peripheral cells
Nursing Interventions: O Place in high Iowler`s position to reduce pulmonary congestion O Administer oxygen in high concentration as prescribed O Prepare Ior intubation and ventilator support iI required O onitor V/S, I&O, CVP, and weight O Diet: low sodium, low Iat, low cholesterol, high potassium, Iluid restriction O Provide adequate rest periods O Administer the II medication as prescribed: 1. orphine sulIate provide sedation & vasodilation 2. Diuretics decrease preload, excretion oI Na & water, decrease circulating blood volume, decrease pulmonary congestion 3. Digitalis increase ventricular contractility, improve cardiac output 4. Inotropics e.g. dopamine, dobutamine
NYHA CLASSIFICATION
Class I: ordinary physical activity doesn`t cause dyspnea or angina; %herapy: ACE inhibitors & Beta blockers (unless contraindicated)
Class II: slight limitation oI physical activity but asymptomatic at rest; ordinary physical activity causes dyspnea or angina; %herapy: sodium restricted diet, diuretics, digoxin, aldosterone antagonists, angiotensin receptor blockers, hydralazine & nitrates
Class III: marked limitation oI physical activity but typically asymptomatic at rest; less than ordinary activity causes dyspnea or angina; %herapy: same with class III
Class IV: unable to perIorm any physical activity without discomIort, symptoms may be present at rest; discomIort increases with physical activity; %herapy: same with class I-III, mechanical assist device, continuous inotropic therapy, hospice care
4. HYPERTENSION O ClassiIication oI prehypertension describes an individual with a systolic BP between 120-139 mmHg or a diastolic pressure between 80-89 mmHg O ajor risk Ior coronary, cerebral, renal & peripheral vascular disease O Hypertensive Urgency: no end organ damage; lower BP within 2-3 days O Hypertensive Emergency: presence oI changes in sensorium, papilledema or heart Iailure; use IV drugs stat; lower BP in 24hrs
Forms oI hypertension: 1. Primary or Essential hypertension O No known cause O Risk Iactors: aging, male, race (blacks), Iamily hx, obesity, smoking, sedentary liIestyle 2. Secondary hypertension O Result oI other disorders or conditions O Risk Iactors: cardiovascular, renal, endocrine disorders, pregnancy, medications
Pathophysiology: O Development oI hypertension arise Irom several theories: O BP CO (SV x HR) x %PR O Increase sympathetic activity O Increase absorption oI sodium and water in the kidneys O Increase activity oI the RAAS O Increase peripheral vascular resistance
Assessment: O Occipital headache O Visual disturbances O Dizziness, tinnitus, epitaxis O Chest pain O Nausea & vomiting
Diagnostic Exams: O UA protein, RBC, WBC glomerulonephritis O FBS increase glucose D O CBC anemia, polycythemia O Lipid proIile increase chole & LDL atherosclerosis O Excretory urography renal diseases O Serum potassium - 3.5 mEq/L primary aldosteronism O BUN & Crea BUN ~ 20 mg/dl, crea ~ 1.2 mg/dl renal disease O EC LVH or ischemic heart disease O CXR cardiomegaly
Interventions: oal: decrease BP, prevent or lessen extent oI organ damage & correct underlying cause O Advise regular exercise program; reduce weight O Stop smoking O Advise to take meds as prescribed and to monitor BP regularly O Stress the importance oI Iollow-up care O Diet: low Iat, low Na 2 gms/day, limit alcohol and caIIeine intake O edications: 1. Diuretics 2. Beta blockers 3. Calcium channel blocker 4. ACE inhibitors 5. A2 receptors blockers 6. Vasodilators
. CARDIAC TAMPONADE O Space between the parietal & visceral layers oI the pericardium Iill with Iluid (20-50 ml) O Restricts ventricular Iilling and reduce CO
Assessment: O Pulsus paradoxus O Increase central venous pressure O ugular venous distention with clear lungs O Distant muIIled heart sounds O Decrease CO and BO
Interventions: O Place in critical care unit Ior hemodialysis monitoring O IV Iluid as prescribed to manage decreased CO O Prepare Ior pericardiocentesis (withdrawal oI pericardial Iluid) O onitor recurrence
. ARTERIAL OCCLUSIVE DISEASE O Chronic disorder in which partial or total arterial occlusion deprives the lower extremities oI oxygen and nutrients O Atherosclerosis is the most common cause
Risk Factors: O smoking, aging, hypertension, hyperlipidemia, D, Iamily history oI vascular disorders, emboli Iormation, thrombosis, trauma or Iracture
Assessment: O 5 P`s (paralysis, paresthesia, pallor, pain & pulselessness) O Pain (intermittent claudication, rest pain, burning, aching, relieved by placing extremities in a dependent position) O Loss oI hair and dry scaly skin O %hickened toenails
Diagnostic Exams: O Arteriography shows type (thrombus or embolus) and degree oI obstruction O Doppler ultrasonography shows reduce blood Ilow distal to occlusion
Interventions: O onitor the extremities Ior 5 P`s O Elevate the Ieet at rest but reIrain Irom elevating them above the level oI the heart because extreme elevation slows arterial blood Ilow to the Ieet O Severe cases, may sleep with aIIected leg hanging Irom the bed or sit upright in a chair O Avoid crossing oI legs, exposure to cold, applying direct heat, tobacco and caIIeine O Advise smoking cessation, hypertension control and walking exercise
edications: O Dextran and antiplatelets O Aspirin, ticlopidine, pentoxiIylline and cilostazol O %hrombolytics O Antilipemics
Surgical procedures: O Embolectomy O %hromboendarterectomy O Patch graIting O Bypass graIting O Lumbar sympathectomy . RAYNAUD`S DISEASE O Vasospasm oI the arterioles in the upper and lower extremities; constriction oI the cutaneous vessels O Attacks are intermittent and occur with exposure to cold or stress O Primarily aIIecting the Iingers, toes, ears, cheeks
Causes: Unknown but associated with several connective tissue disorders
Pathophysiology: O Intrinsic vascular wall hyperactivity to cold O Increase vasomotor tone due to sympathetic stimulation O Antigen-antibody immune complex
Assessment: O Blanching Iollowed by cyanosis during vasoconstriction O Numbness, tingling, swelling and cold temperature at the aIIected body part
Interventions: O Instruct to avoid precipitating Iactors such as cold and stress O Instruct to avoid smoking O Instruct to wear warm clothing, socks and gloves in cold weather
edications: O Ca channel blockers vasodilation; prevent vasospasm O Adrenergic blockers improves blood Ilow , e.g. phenoxybenzamine (Reserpine)
. BUERGER`S DISEASE (THROMBOANGITIS OBLITERANS) O Occlusive disease oI the median and small arteries and veins O Distal upper and lower limbs are aIIected O AIIects men 20-35 yrs old O Risk Iactor: smoking
Assessment: O Intermittent claudication O Aching pain, severe at night O Intense redness, progressing to cyanosis O Cool, numb, tingling sensation O Diminished pulses in distal extremities O Development oI ulcer
Diagnostic Exam: O Duplex ultrasonography O Contrast angiography
Interventions: O Instruct to stop smoking O onitor pulses O Advise to avoid injury to upper and lower extremities O Administer vasodilators as prescribed
. PHLEBITIS
Assessment: O Red, warm area O Pain and soreness O Swelling
Interventions: O Apply warm moist soaks to dilate the vein and promote circulation O Assess signs oI complications: tissue necrosis, inIection, or pulmonary embolus
10.DEEP VEIN THROMBOSIS O Acute condition characterized by inIlammation and thrombus Iormation O AIIects small veins or large veins e.g. vena cava, Iemoral, iliac and subclavian veins O Progressive, may lead to pulmonary embolism
Causes: O Idiopathic O Results Irom endothelial damage, accelerated blood clotting or reduced blood Ilow
Risk Factors: O Prolonged bed rest, trauma, childbirth, use oI hormonal contraceptives
Pathophysiology: Alteration in epithelial lining
Platelet aggregation Fibrosis entrapment oI RBC, WBC
%hrombus Iormation
Chemical inIlammatory process in the vessel epithelium
Fibrosis
Occlusion oI vessel lumen Embolize
Assessment: O CalI or groin tenderness or pain with or without swelling O () homan`s sign O %ender, warm skin O Fever, chills, malaise
Diagnostic Exams: O Doppler ultrasonography identiIies decrease blood Ilow and any obstruction to venous Ilow O Venography conIirms diagnosis; shows Iilling deIects and diverted blood Ilow
Interventions: O oal: control thrombus Iormation, prevent complications, relieve pain & prevent recurrence O Provide bed rest O Elevate aIIected extremity above the level oI the heart O Using knee gatch or pillow under the knees O Do not massage extremity O Advise to wear anti-embolic stockings (decrease venous stasis and to assist venous return) O onitor Ior shortness oI breath and chest pain Ior pulmonary embolism O Administer the II medications as prescribed: O %hrombolytic therapy (tissue plasminogen activator) initiated 5 days aIter onset oI symptoms O Heparin prevent enlargement oI existing clot and Iormation oI new clots O WarIarin (Coumadin) Iollowing heparin therapy O Analgesics decrease pain O Diuretics decrease edema O onitor side eIIects and hazards oI anticoagulant therapy O onitor Prothrombin time O Surgical management: vein stripping & graIting
11.VARICOSE VEINS O Distended, protruding veins that appear darkened and tortuous O Vein walls weaken and dilate, valves become incompetent
Risk Iactors: pregnancy, prolonged standing or sitting
Assessment: O Dull, aching pain in the legs aIter standing O Ankle edema O () trendelenburg`s test
Interventions: O Emphasize the use oI antiembolic stockings O Instruct to elevate legs as much as possible O Instruct to avoid constrictive clothing O Prepare client Ior sclerotherapy or vein stripping as prescribed
COMMON CARDIAC DRUGS 1. Nitrates dilate coronary arteries; to decrease preload and aIter load 2. Calcium channel blocker dilate coronary arteries & reduce spasm 3. Beta blockers reduce BP & heart rate 4. Aspirin prevent thrombus Iormation 5. Cholesterol Lowering medications reduce development oI atherosclerotic plaque